Endometriosis

Endometriosis in horses refers to degenerative changes within the uterine lining characterized by progressive fibrosis and structural deterioration of the endometrial glands. Unlike the condition in humans where endometrial tissue grows outside the uterus, equine endometriosis describes intrauterine pathology involving the accumulation of fibrous connective tissue around and between endometrial glands, ultimately compromising the uterus's ability to support pregnancy. This degenerative process represents one of the most significant causes of subfertility and pregnancy loss in mares, particularly those of advancing age. Understanding equine endometriosis is essential for anyone involved in mare reproductive management and breeding decisions.

Endometriosis affects mares across all breeds, with prevalence increasing substantially with age and reproductive wear. Studies suggest that over seventy percent of mares above fifteen years of age have some degree of endometrial fibrosis detectable on biopsy. The condition progresses gradually, often developing over years before becoming clinically significant. Multiparous mares that have experienced numerous pregnancies may show earlier or more severe changes than maiden mares of similar age, though age remains the primary determinant. Both breeding and non-breeding mares develop endometriosis, as the degenerative process continues regardless of reproductive activity.

The impact of endometriosis on mare fertility ranges from minimal to profound depending on disease severity. Mild fibrotic changes may not significantly affect pregnancy rates, while moderate to severe endometriosis substantially reduces the likelihood of conception and pregnancy maintenance. Affected uterine glands cannot produce the secretions necessary to nourish the early embryo before placental attachment. Fibrotic endometrium provides poor support for placental development, increasing risks of pregnancy loss throughout gestation. The histopathological grading of endometrial biopsy samples provides the most reliable prediction of expected foaling rates for individual mares.

While endometriosis cannot be reversed, understanding its nature and severity in individual mares allows appropriate breeding management decisions. Mild cases often produce successful pregnancies with standard management. Moderate cases may benefit from enhanced reproductive support and early pregnancy monitoring. Severe cases carry poor prognosis regardless of intervention, allowing realistic discussions about breeding prospects. Treatment focuses on managing concurrent conditions that may accelerate progression, optimizing conditions for pregnancy when attempted, and helping mare owners make informed decisions about reproductive use.

The primary causes of equine endometriosis center on cumulative damage and age-related degeneration of the uterine lining. The normal healing response to any uterine insult involves inflammation followed by tissue repair, and repeated cycles of damage and repair gradually result in fibrous tissue accumulation. Over time, this fibrosis progressively replaces functional glandular tissue with inactive scar tissue. The process accelerates with age as regenerative capacity diminishes and inflammatory responses become less efficiently resolved. Natural aging of endometrial tissues contributes independently of external insults, explaining why even well-managed maiden mares develop fibrosis with advancing years.

Genetic and breed predispositions for endometriosis development have not been clearly established in horses. All breeds appear susceptible to age-related endometrial degeneration without significant variation in onset or progression rates. No heritable markers have been identified that predict endometriosis risk. The lack of breed predisposition suggests that endometriosis represents a universal aging process rather than a genetically determined condition. Individual variation in progression rates likely reflects differences in inflammatory history and uterine health rather than genetic susceptibility.

Environmental and management factors influence endometriosis primarily through their effects on uterine inflammation and infection. Chronic or recurrent endometritis provides repeated inflammatory stimuli that drive fibrotic progression. Poor breeding hygiene introduces contamination that provokes inflammatory responses. Inadequate post-breeding uterine clearance allows prolonged exposure to inflammatory triggers. Retained placenta following foaling causes significant uterine damage if not promptly addressed. Management that minimizes uterine insults may slow progression, while poor reproductive management accelerates degenerative changes. However, even optimally managed mares eventually develop age-related fibrosis.

Risk factors for endometriosis development and progression include age, parity, uterine infection history, and anatomical conformational defects. Advancing age is the strongest predictor, with changes becoming increasingly prevalent after age twelve to fifteen. High parity, particularly with short intervals between pregnancies, exposes the endometrium to repeated gestational changes. History of severe or recurrent endometritis accelerates fibrotic progression. Mares with poor perineal conformation predisposing to pneumovagina experience chronic contamination that promotes inflammation. Cervical incompetence allows ascending infection and continued uterine damage. Difficult foaling or retained placenta causes acute damage that heals with increased fibrosis.

The pathophysiology of equine endometriosis involves the gradual replacement of functional endometrial tissue with non-functional fibrous tissue. Normal endometrium contains abundant glands that produce uterine secretions (histotroph) essential for early embryo nutrition. These glands are surrounded by a supporting stromal network. With endometriosis, collagen accumulates around glands (periglandular fibrosis), progressively strangling glandular function. Glands become dilated, atrophic, or completely replaced by scar tissue. The stromal compartment also undergoes fibrotic change, losing the normal architecture necessary for pregnancy support. Advanced cases show extensive glandular nesting, where isolated glands become trapped in dense fibrous tissue incapable of normal secretory function.

Early warning signs of endometriosis are typically absent in the early stages of disease development. Mares with mild endometrial fibrosis usually cycle normally, breed readily, and may successfully maintain pregnancies without any indication of underlying pathology. The condition develops silently over years, with no external signs alerting owners to progressive changes. Early detection requires proactive uterine biopsy examination rather than recognition of clinical symptoms. By the time fertility problems become apparent, significant degenerative changes have usually already occurred. This silent progression underscores the value of baseline reproductive evaluation before initiating breeding programs in mares.

Common symptoms of clinically significant endometriosis relate primarily to reproductive failure rather than observable clinical signs. Affected mares may fail to conceive despite apparently successful breeding and confirmed ovulation. Early embryonic death occurs when the damaged endometrium cannot adequately nourish the developing embryo. Pregnancy losses may occur at any gestational stage as placental function becomes compromised. Some mares conceive and maintain pregnancy initially but lose foals in mid to late gestation. Repeated breeding failure across multiple cycles suggests endometrial pathology warranting investigation. These reproductive symptoms are not specific to endometriosis and require biopsy for definitive diagnosis.

Behavioral changes directly attributable to endometriosis are not observed, as the condition causes no pain or discomfort that would alter mare demeanor. Affected mares continue to cycle normally, showing appropriate estrous behavior and accepting breeding without difficulty. Temperament, appetite, and activity levels remain unchanged by endometrial pathology. Any behavioral changes in mares with endometriosis are more likely related to concurrent conditions or coincidental factors. The absence of behavioral symptoms contributes to the condition's silent progression and delayed recognition.

Physical signs of endometriosis are not detectable through external observation or routine physical examination. The mare's external appearance, body condition, and general health provide no indication of endometrial status. Transrectal palpation may detect abnormal uterine texture in severe cases, with affected uteri sometimes feeling more firm or irregular, though this is inconsistent and nonspecific. Vaginal speculum examination and cervical evaluation may reveal concurrent inflammatory conditions but cannot diagnose endometriosis specifically. Ultrasound examination may show increased endometrial echogenicity in advanced cases but cannot reliably detect or stage fibrotic changes. Definitive diagnosis requires histopathological examination of uterine biopsy samples.

Symptom progression in endometriosis reflects the gradual nature of degenerative change. Mares may produce foals successfully for years before fibrosis accumulates sufficiently to compromise fertility. The transition from successful breeding to reproductive failure may occur gradually or seem relatively sudden when disease crosses a functional threshold. Serial uterine biopsies over time document histopathological progression. Fertility tends to decline in stepwise fashion corresponding to worsening biopsy grades. Once significant fibrosis develops, progression continues regardless of reproductive activity, though the rate of change varies among individuals.

Emergency symptoms related to endometriosis are not encountered, as the condition develops gradually and causes no acute health crisis. Endometriosis itself does not cause colic, fever, or other urgent clinical signs. Mares with endometriosis may experience obstetric emergencies or pregnancy complications that require urgent care, but these result from pregnancy itself rather than underlying endometrial pathology. The management of endometriosis remains entirely elective and planned, focused on long-term reproductive decision-making rather than emergency intervention.

Physical examination of mares suspected of endometriosis includes comprehensive reproductive tract evaluation. General examination assesses overall health, body condition, and any factors that might influence reproductive function. External perineal conformation is evaluated for vulvar angle and potential pneumovagina predisposing to chronic contamination. Transrectal palpation assesses uterine size, symmetry, tone, and texture, though changes are often subtle until disease is advanced. Vaginal speculum examination evaluates cervical health, presence of discharge, and vaginal integrity. These examinations may reveal concurrent conditions contributing to uterine pathology but cannot diagnose endometriosis specifically.

Diagnostic tests for endometriosis definitively require uterine biopsy with histopathological examination. Biopsy samples are obtained transcervically using specialized instruments and submitted to pathology laboratories experienced in equine reproductive interpretation. Histopathology reveals the characteristic periglandular fibrosis, glandular changes, and stromal alterations diagnostic of endometriosis. The Kenney-Doig grading system classifies endometrial quality into categories predicting expected foaling rates: Grade I indicates normal endometrium with greater than eighty percent foaling expectation; Grade IIA shows mild changes with fifty to eighty percent expected success; Grade IIB demonstrates moderate changes with ten to fifty percent success; Grade III reveals severe changes with less than ten percent expected foaling rate.

Advanced diagnostics supplement biopsy findings and provide additional reproductive assessment. Uterine culture and cytology identify concurrent bacterial infection requiring treatment. Ultrasonography evaluates uterine structure, detects fluid accumulation, and identifies endometrial cysts commonly accompanying fibrotic changes. Hysteroscopy provides direct visualization of the endometrial surface, though changes seen are not specific for fibrosis. Low-volume uterine lavage allows cytological assessment of inflammatory status. Hormone profiling may be performed if ovarian dysfunction is suspected as a contributing factor. These tests help characterize overall reproductive health but biopsy remains essential for endometriosis diagnosis and staging.

Differential diagnosis for mares with reproductive failure potentially related to endometriosis must consider other conditions causing similar clinical pictures. Chronic endometritis produces recurrent pregnancy loss but represents active infection rather than degenerative fibrosis. Endometrial cysts may interfere with pregnancy without necessarily indicating fibrotic change. Ovarian dysfunction, cervical abnormalities, and oviductal blockage cause subfertility through different mechanisms. Chromosomal abnormalities in embryos result in early pregnancy loss regardless of endometrial quality. Thorough diagnostic workup including biopsy allows appropriate identification of contributing factors and guides management decisions.

Emergency treatment is not applicable to endometriosis, as the condition represents chronic degenerative change rather than acute crisis. All management decisions for mares with endometriosis are made electively based on reproductive goals and disease severity. The gradual nature of the condition allows thorough evaluation and careful planning without urgency. Treatment efforts focus on optimizing conditions for pregnancy in mares where breeding is attempted and providing realistic prognostic information for reproductive decision-making.

Medical management of endometriosis aims to address concurrent conditions that may accelerate progression and optimize the uterine environment for pregnancy when breeding is attempted. Treatment of any active endometritis through appropriate antibiotic therapy, uterine lavage, and ecbolic agents reduces ongoing inflammatory stimuli. Progesterone supplementation during early pregnancy may support marginal endometrium in maintaining pregnancy. Intrauterine plasma or platelet-rich plasma treatments have been explored as regenerative therapies, though evidence for efficacy in reversing established fibrosis remains limited. Medical management cannot reverse existing fibrotic damage but may slow further progression and improve immediate breeding attempts.

Surgical options for endometriosis are limited, as the diffuse nature of endometrial fibrosis does not lend itself to surgical correction. No procedure can restore normal endometrial architecture once significant degeneration has occurred. Surgical procedures may address contributing factors, such as Caslick's vulvoplasty for mares with poor perineal conformation that allows chronic contamination. Cervical adhesions or scarring may be surgically addressed if present. Treatment of concurrent ovarian abnormalities may require surgical intervention. However, these procedures address associated conditions rather than endometriosis itself.

Supportive care for mares with endometriosis focuses on general reproductive health optimization. Maintaining appropriate body condition supports overall reproductive function. Reducing stress through stable management and minimized disruption supports hormonal balance. Pre-breeding treatment of any uterine inflammation prepares the best possible environment for embryo reception. Enhanced monitoring during pregnancy allows early detection of problems when intervention might help. General health maintenance ensures the mare can support pregnancy demands even with compromised endometrial function.

Rehabilitation and return to breeding for mares with endometriosis requires realistic assessment of success likelihood. Mares with Grade I or IIA biopsies often breed successfully with standard management. Those with Grade IIB results face reduced expectations but may achieve pregnancy with enhanced reproductive support, early pregnancy monitoring, and sometimes progesterone supplementation. Mares with Grade III biopsies have poor prognosis regardless of intervention, and breeding attempts often result in frustrating repeated failure. Honest discussion of expected outcomes helps owners make appropriate decisions about pursuing breeding versus retirement from reproduction.

Treatment decision factors for endometriosis include biopsy grade, mare age, reproductive value, number of desired foals, and concurrent conditions. Young mares with mild changes have good prognosis and warrant standard breeding management. Older mares with moderate fibrosis may justify enhanced support if obtaining even one foal is valuable. Severely affected mares rarely produce foals regardless of effort, and realistic counseling prevents prolonged unsuccessful breeding attempts. Economic considerations including breeding costs, embryo transfer options, and mare value influence decisions. The irreversible nature of endometriosis limits therapeutic options but does not preclude successful pregnancy in appropriate cases.

Recovery timeline concepts differ for endometriosis compared to acute conditions, as this degenerative process does not resolve or heal. Once endometrial fibrosis develops, the tissue changes persist permanently. Treatment can address concurrent inflammation, and periods between breeding may allow the uterine environment to optimize, but the underlying fibrotic damage remains. Recovery discussions focus on returning to breeding condition following specific interventions or pregnancy rather than recovering from endometriosis itself. Mares may have successful pregnancies despite persistent endometrial changes if disease severity allows.

Post-treatment care and monitoring for mares with endometriosis emphasizes ongoing reproductive surveillance. Regular veterinary evaluation tracks disease progression through serial biopsies when indicated. Pre-breeding examination before each breeding attempt assesses current uterine status. Early and frequent pregnancy monitoring detects problems when intervention might help maintain pregnancy. Post-foaling evaluation determines whether pregnancy and parturition have accelerated degenerative changes. Continued attention to factors that might worsen progression, including prompt treatment of any uterine infection, supports optimal reproductive function within the limits imposed by existing damage.

Prognosis factors for mares with endometriosis center on histopathological biopsy grade, which provides the most reliable prediction of expected reproductive success. Grade I mares have essentially normal expectations despite minor changes. Grade IIA mares experience moderately reduced but still reasonable success rates. Grade IIB mares face significantly compromised fertility, though pregnancy remains possible. Grade III mares have poor prognosis with expected foaling rates below ten percent. Additional factors modifying prognosis include mare age, presence of concurrent conditions, and response to management of any treatable abnormalities. Progression between biopsy grades over time indicates declining fertility prospects.

Long-term fertility outlook for mares with endometriosis follows predictably declining trajectories as fibrosis progresses and age compounds degenerative changes. Even mares that produce foals may experience worsening fertility with subsequent breeding attempts. Each pregnancy stresses the compromised endometrium, potentially accelerating progression. Mares intended for multiple foals should begin breeding programs early to accomplish reproductive goals before advanced degeneration. Those with significant fibrosis already present may realistically expect only one or two additional foals, if any. Embryo transfer to surrogate mares offers an option for obtaining offspring from genetically valuable mares when their own uteri cannot support pregnancy.

Management practices for preventing endometriosis focus on minimizing uterine insults that accelerate fibrotic progression, though some degree of age-related degeneration is inevitable. Excellent breeding hygiene reduces contamination and resulting inflammation. Proper management of post-breeding uterine clearance in susceptible mares prevents prolonged exposure to inflammatory fluid. Prompt attention to retained placenta after foaling minimizes severe uterine damage. Correction of conformational defects predisposing to chronic contamination reduces ongoing inflammatory stimuli. These practices may slow progression but cannot completely prevent eventual development of age-related changes.

Nutritional prevention strategies for endometriosis lack specific evidence, as the condition's degenerative nature does not respond to dietary modification. Maintaining optimal body condition supports general reproductive health. Adequate selenium and vitamin E support immune function and tissue health. Omega-3 fatty acids may have general anti-inflammatory benefits. No specific nutrients or supplements have demonstrated efficacy in preventing endometrial fibrosis. Sound nutrition contributes to overall mare health without specifically targeting endometriosis prevention.

Exercise and conditioning do not directly influence endometriosis development, as the condition arises from intrinsic uterine factors rather than fitness-related variables. Maintaining appropriate fitness for the mare's intended use supports general health without specific effects on endometrial pathology. Exercise neither prevents nor accelerates fibrotic progression. Recommendations regarding activity levels relate to pregnancy support and general management rather than endometriosis prevention.

Environmental factors affecting endometriosis relate primarily to potential sources of uterine contamination. Clean breeding environments reduce infectious exposure. Appropriate stallion selection and semen handling minimize contamination during artificial insemination. Prompt post-foaling care prevents retained placenta complications. Housing that maintains dry, clean conditions supports reproductive health. These environmental factors influence the inflammatory insults that drive progression rather than preventing the underlying degenerative process.

Reproductive timing strategies may help accomplish breeding goals before endometriosis significantly impairs fertility. Breeding mares earlier in their lives, while endometrial quality remains good, optimizes success rates. Spacing pregnancies to allow uterine recovery between foalings may reduce cumulative damage. Completing desired production before age-related changes accumulate preserves reproductive success. Baseline biopsy evaluation before beginning breeding programs provides reference for monitoring progression. These timing-focused approaches work around the inevitable nature of endometrial aging rather than preventing it.

Daily management adjustments for mares with endometriosis are unnecessary outside of breeding-related considerations. The condition causes no pain, discomfort, or functional impairment affecting daily life. Affected mares can be used normally for riding, competition, or any other purpose without modification for their endometrial status. Feeding, turnout, exercise, and general care proceed according to the mare's other needs without specific requirements related to endometriosis. The condition has no impact on quality of life outside of reproductive concerns.

Housing and turnout considerations for mares with endometriosis focus on reproductive management when breeding is planned. Clean, well-maintained facilities support reproductive health generally. Minimizing exposure to potential sources of uterine contamination helps prevent worsening inflammation. Standard housing appropriate for the mare's age, condition, and use applies without specific modifications for endometriosis. If the mare is retired from breeding, housing and management proceed without reproductive considerations.

Exercise modifications for mares with endometriosis are not required, as the condition does not affect soundness or performance capacity. Training and competition continue normally regardless of endometrial status. During pregnancy, mares with endometriosis follow standard pregnancy exercise guidelines. Light exercise during early pregnancy supports circulation and general health. The presence of endometriosis does not change exercise recommendations, which are determined by the mare's fitness level, discipline, and pregnancy status.

Monitoring and ongoing care for breeding mares with diagnosed endometriosis emphasizes reproductive surveillance and optimization of breeding attempts. Pre-breeding examination assesses current uterine status before each breeding cycle. Uterine biopsy may be repeated every few years or after significant reproductive events to document progression. Early and frequent pregnancy monitoring during the first sixty days detects problems when intervention might help. Ongoing attention to factors affecting uterine health, including prompt treatment of any infection, supports best possible reproductive function.

Quality of life and use considerations for mares with endometriosis center on appropriate reproductive decision-making. The mare's quality of life is not affected by endometriosis outside of reproduction. Decisions about continuing breeding attempts balance realistic fertility expectations against the emotional and economic costs of repeated failure. Mares with severe changes producing repeated disappointment may have better quality of life retired from breeding programs. Those with milder changes may continue producing foals with appropriate management. Embryo transfer to surrogate mares provides an alternative for obtaining offspring from mares whose own uteri cannot support pregnancy, allowing retirement from carrying foals while still contributing genetics to breeding programs.

High-risk breeds for endometriosis have not been identified, as the condition develops based on age and uterine history rather than breed characteristics. Studies examining endometrial biopsy findings across breeds consistently show that age is the primary determinant of fibrosis severity, with breed having no significant independent effect. Thoroughbreds, Warmbloods, Quarter Horses, Arabians, draft breeds, and ponies all develop endometriosis at similar rates when age is controlled. The apparent prevalence differences sometimes reported likely reflect age distributions within breeding populations and frequency of veterinary examination rather than true breed susceptibility.

Use and discipline considerations affecting endometriosis relate to reproductive timing and management intensity rather than work type. Performance disciplines that delay breeding until after competition careers extend mare age at first breeding, increasing the likelihood of significant fibrosis being present when reproduction is attempted. Breeds and disciplines that breed mares younger may accomplish reproductive goals before advanced degeneration occurs. High-volume breeding programs that breed mares repeatedly without adequate recovery between pregnancies may accelerate progression. Careful reproductive management regardless of discipline optimizes outcomes for individual mares.

Genetic testing and breeding recommendations for endometriosis are not applicable, as no genetic basis for the condition has been established. Endometriosis is not heritable and does not warrant consideration in breeding decisions beyond effects on the individual mare's fertility. Daughters of affected mares do not have increased endometriosis risk. When mares with significant endometriosis produce offspring through embryo transfer or during earlier years before advanced changes, those offspring do not carry predisposition for endometrial problems. Breeding recommendations focus on timing and management for the affected individual rather than avoiding genetic transmission.

Commonly co-occurring conditions with endometriosis include other manifestations of reproductive tract aging and degeneration. Endometrial cysts frequently accompany fibrotic changes, with both conditions reflecting age-related lymphatic and tissue dysfunction. Chronic endometritis often coexists, with inflammatory changes driving fibrotic progression. Cervical incompetence develops with age and may allow ascending contamination worsening uterine pathology. Ovarian dysfunction including irregular cycling or anovulation may occur in older mares with concurrent endometrial problems. The combination of multiple degenerative changes typically has greater impact on fertility than any single finding, and thorough evaluation identifies all contributing factors.

Conditions with similar symptoms to endometriosis, specifically reproductive failure, encompass the full range of fertility problems in mares. Infectious endometritis causes conception failure and pregnancy loss but represents active infection rather than degenerative change. Ovarian pathology including granulosa cell tumors affects hormone production and cycling. Oviductal blockage prevents fertilization regardless of endometrial quality. Chromosomal abnormalities cause early embryonic death independent of maternal uterine factors. Placentitis and other pregnancy-specific conditions cause losses that may be attributed to endometriosis without thorough evaluation. Complete reproductive workup including biopsy accurately identifies endometriosis versus other causes of subfertility.

Potential complications of endometriosis primarily involve progressive reproductive deterioration and pregnancy complications. Pregnancy loss may occur at any gestational stage as compromised endometrium cannot adequately support placental development and function. Placentitis risk may increase with abnormal placental attachment. Mares with poor endometrial quality may have weakened uterine muscle function affecting foaling. The progressive nature of the condition means fertility typically declines over time regardless of management. Early recognition and realistic counseling prevent the complication of prolonged breeding frustration when prognosis is poor, while allowing appropriate intervention when pregnancy remains achievable.